OBJECTIVE: Determine the efficacy of computerized tomography (CT) in detecting the intranasal distribution of sprayed radio-enhanced particles and the effects of topical decongestion on particle distribution.
STUDY DESIGN: Sinonasal distribution of a radio-enhanced spray solution was studied using CT imaging in 14 adults with no sinonasal symptoms. One nostril was sprayed with oximetazoline 5 minutes prior to particle application. Serial CT imaging of the sinonasal cavity in approximately 11 minutes was carried out to detect particle distribution into the nasal vestibule, turbinate surfaces, middle meatus and osteomeatal complex area, and the nasopharynx.
RESULTS: Particle detection within the nasal vestibule was possible in all cases while distribution into the anterior nasal chamber was visible in 22 cases. Particles could be detected on the inferior turbinate in 7 nasal cavities (25%) and in only 2 cases on the middle turbinate (7.5%). Particles were detected in the middle meatus in 1 case and in no instances in the osteomeatal complex area. Oximetazoline application reduced the amount of particle deposition on the inferior turbinate but did not enhance distribution on the middle turbinate or into the middle meatus.
CONCLUSION: Detection of radio-enhanced sprayed particles within the sinonasal cavity using CT imaging can be a reliable method to study the principles of intranasal particle distribution. Our study failed to show particle distribution into OMC, or any positive effects of nasal decongestion on particle distribution.
EBM RATING: C
Get full access to this article
View all access options for this article.
References
1.
NewmanSPSpeedKPHardyJG, et al. The distribution of an intranasal insulin formulation in healthy volunteers: Effects of different administration techniques. J Pharm Pharmacol1994;46:657–60. (Grade A).
2.
NewmanSPPitcairnGRDalbyRNDrug delivery to the nasal cavity: In vitro and in vivo assessment. Crit Rev Ther Drug Carrier Syst2004;21:21–66. (Grade C).
3.
JenAKackerAHuangC, et al. Fluconazole nasal spray in the treatment of allergic fungal sinusitis: A pilot study. Ear Nose Throat J2004;83:692–5. (Grade B).
4.
TsikoudasAHomerJJThe delivery of topical nasal sprays and drops to the middle meatus: A semiquantitative analysis. Clin Otolaryngol2001;26:294–7. (Grade A).
5.
MillerTRMantzHRGilbertME, et al. Comparison of topical delivery systems after sinus surgery. Laryngoscope2004;114:201–4. (Grade A).
6.
BenningerMSHadleyJAOsguthorpeDJ, et al. Techniques of intranasal steroid use. Otolaryngol Head Neck Surg2004;130:5–24. (Grade A).
7.
DayalPShaikMSSinghM.Evaluation of different parameters that affect droplet size distribution from nasal sprays using the Malvern Spraytec. J Pharm Sci2004;93:1725–42. (Grade A).
8.
KubbaHSpinouERobertsonA.The effect of head position on the distribution of drops within the nose. Am J Rhinol2000;14:83–6. (Grade C).
9.
BatemanNDWhymarkADCliftonNJ, et al. A study of intranasal distribution of azelastine hydrochloride aqueous nasal spray with different spray techniques. Clin Otolaryngol2002;27:327–30. (Grade B).
10.
DowleyACHomerJJThe effects of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus. Clin Otolaryngol2001;26:488–90. (Grade A).
11.
KesevanJBascomRLaubeB, et al. The relationship between particle deposition in the anterior nasal passage and nasal passage characteristics. J Aeresol Med2000;13:17–23. (Grade A).
12.
SamanJDLaubeBLLinTC, et al. Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition. Pharm Res2002;19:1–6. (Grade A).
13.
ChengYSHolmesTDGaoJ, et al. Characterization of nasal spray pumps and deposition patterns in a replica of the human nasal airway. J Aeresol Med2001;14:267–80. (Grade D).
14.
NewmanSPMorenFClarkeSWDeposition pattern of nasal sprays in man. Rhinology1988;26:111–20. (Grade A).
15.
SaijoRMajimaYHyoN, et al. Particle deposition of therapeutic aeresols in the nose and paranasal sinuses after transnasal sinus surgery: A cast model study. Am J Rhinol2004;18:1–7. (Grade D).
